HomeBiotech

Biotech

ESMO 2024 – ImmVira Unveils Clinical Results of Intravesical MVR-T3011 for High-Risk BCG-Failure NMIBC Patients

ESMO 2024 – ImmVira Unveils Clinical Results of Intravesical MVR-T3011 for High-Risk BCG-Failure NMIBC Patients

September 15, 2024

ESSA Pharma Presents Updated Phase 1/2 Masofaniten (EPI-7386) Clinical Data at the 2024 ESMO Congress

ESSA Pharma Presents Updated Phase 1/2 Masofaniten (EPI-7386) Clinical Data at the 2024 ESMO Congress

September 14, 2024

Live from ESMO 2024 | Ascentage Pharma Releases Latest Data Showing Sustained Clinical Efficacy of Olverembatinib in SDH-Deficient GIST during a Mini Oral Presentation

Live from ESMO 2024 | Ascentage Pharma Releases Latest Data Showing Sustained Clinical Efficacy of Olverembatinib in SDH-Deficient GIST during a Mini Oral Presentation

September 14, 2024

Nuvalent Highlights Presentation of Clinical Data at ESMO 2024 for Parallel Lead Programs for ROS1 and ALK-positive NSCLC and Accelerated Development Timelines

Nuvalent Highlights Presentation of Clinical Data at ESMO 2024 for Parallel Lead Programs for ROS1 and ALK-positive NSCLC and Accelerated Development Timelines

September 14, 2024

Nona Biosciences Enters into Collaboration Agreement with Umoja Biopharma to Advance In Vivo CAR-T Cell Therapies

Nona Biosciences Enters into Collaboration Agreement with Umoja Biopharma to Advance In Vivo CAR-T Cell Therapies

September 13, 2024

Alume Biosciences Appoints Rick Gonzalez as Chief Commercial Officer

Alume Biosciences Appoints Rick Gonzalez as Chief Commercial Officer

September 13, 2024

Aetion Announces Leadership Changes

Aetion Announces Leadership Changes

September 13, 2024

BMC at ERS 2024: Exploring the Future of Sleep and Respiratory Health

BMC at ERS 2024: Exploring the Future of Sleep and Respiratory Health

September 12, 2024

Ryvu Therapeutics Reports 2024 Half-Year Financial Results and Provides Corporate Update

Ryvu Therapeutics Reports 2024 Half-Year Financial Results and Provides Corporate Update

September 12, 2024

Biolexis Unveils Promising Data with an Oral Weight Loss Drug: BLX-7006 Shows Significant Results in Preclinical Studies

Biolexis Unveils Promising Data with an Oral Weight Loss Drug: BLX-7006 Shows Significant Results in Preclinical Studies

September 12, 2024

« 1 … 20 21 22 23 24 … 81 »